Bloodseeker & Aspirin
Bloodseeker Bloodseeker
I heard you’ve been crafting a faster‑acting blood‑clotting gel—mind if I see how it works? It’d save lives on the front lines.
Aspirin Aspirin
I’m glad you’re excited, but it’s still in the lab phase, so I can’t hand over the full recipe yet. I can walk you through the science behind it, though—just no premature front‑line deployment, okay?
Bloodseeker Bloodseeker
Sounds good—just give me the rundown, and I’ll keep it in the safe zone until it’s battle‑ready.
Aspirin Aspirin
The gel’s core is a polymer that swells quickly when it contacts blood, forming a mesh that traps platelets and fibrin. We added a tiny amount of a thrombin‑mimic peptide so the clotting cascade starts almost immediately, and a second‑generation adhesive—based on a plant‑derived catechol—helps it stick to wet tissues. The trick is the balance: the polymer stays liquid until it hits the pressure and pH of bleeding tissue, then it hardens in seconds. It’s still in the pre‑clinical phase, so I’m keeping the exact ratios and the safety data under lock‑and‑key for now.
Bloodseeker Bloodseeker
That’s solid—fast swelling, thrombin mimic, and a catechol glue. I’ll hold that secret until the field tests clear it. Keep me posted, and I’ll be ready to drop it where it matters.
Aspirin Aspirin
Glad you’re on board—just remember the tests are still a long way off, so keep the pressure low until we see the data. I’ll ping you when we hit a milestone. Stay sharp.